Results 131 to 140 of about 948 (174)

Hypophosphatasia: Enzyme Replacement Therapy (Asfotase Alfa) Decreases TNSALP Substrate Accumulation And Improves Functional Outcomes In Affected Adolescents And Adults [PDF]

, 2012
Greenberg, C R, Kishnani, P S, Kreher, N, Landy, H, Mack, K, Madson, K, Mhanni, A, Plotkin, H, Weber, T, Whyte, M P   +9 more
core   +1 more source

Improvement in quality of life after asfotase alfa treatment in adults with pediatric-onset hypophosphatasia: data from 5 patient-reported outcome measures. [PDF]

JBMR Plus
Dahir KM, Ing SW, Deal C, Messali A, Bates T, Rush ET.   +5 more
europepmc   +1 more source

ALPL genotypes in patients with atypical femur fractures or other biochemical and clinical signs of hypophosphatasia [PDF]

, 2022
and Maria Luisa Brandi,, Cianferotti, Luisella, Emmanuel, Biver, Federica, Cioppi, Giovanni, Iolascon, Giuseppe, Toro, Giusti, Francesca, Iantomasi, Teresa, Laura, Masi, Marcucci, Gemma, Marini, Francesca, Simone, Ciuffi   +11 more
core  

Improvement of bone microarchitecture parameters after 12 months of treatment with asfotase alfa in adult patient with hypophosphatasia: Case report. [PDF]

Medicine (Baltimore), 2018
Freitas TQ, Franco AS, Pereira RMR.
europepmc   +1 more source

Hypophosphatasia-pathophysiological understanding, preclinical data looking beyond the skeleton, and upcoming treatments. [PDF]

J Bone Miner Res
Millán JL.
europepmc   +1 more source

Asfotase alfa for hypophosphatasia.

Australian prescriber
openaire   +1 more source